Endo International Plc filed for bankruptcy on Tuesday after reaching a $6 billion deal with some of its creditors, as the U.S. drugmaker seeks to settle thousands of lawsuits over its alleged role in the country’s opioid epidemic.
https://www.pharmalive.com/wp-content/uploads/2022/08/Endo-logo-2022.jpg500600Reuters Healthhttps://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.pngReuters Health2022-08-17 04:52:372022-08-17 08:48:14Endo files for bankruptcy as U.S. opioid litigation drags